Munkvad S, Jespersen J, Gram J, Kluft C
Department of Clinical Chemistry, Ribe County Hospital, Esbjerg, Denmark.
J Intern Med. 1990 Oct;228(4):361-6. doi: 10.1111/j.1365-2796.1990.tb00246.x.
Patients with unstable angina pectoris (UAP; n = 20) and acute myocardial infarction (AMI; n = 34) were studied in the acute phase of ischaemic heart disease. We found significantly higher levels of thrombin-antithrombin-III (TAT) complexes, lower levels of systemic tissue plasminogen activator (t-PA) activity, and higher levels of plasminogen activator inhibitor (PAI) activity in the AMI patients compared to the UAP patients. In contrast to these specific changes, general acute phase reactants such as C-reactive protein, fibrinogen and von Willebrand factor did not differ significantly between the two groups. Studies of the relationship between coagulation (TAT-complexes) and fibrinolysis data revealed a significant positive correlation between plasma antigen concentrations of TAT-complexes and t-PA (P less than 0.02), and between TAT-complexes and PAI-I (P less than 0.002). These observations indicate a common pathophysiological mechanism underlying the changes in coagulation and fibrinolysis, suggesting that coagulation activity and t-PA-related fibrinolysis are interrelated processes in vivo, and probably take place at the level of the endothelial cell.
对20例不稳定型心绞痛(UAP)患者和34例急性心肌梗死(AMI)患者在缺血性心脏病急性期进行了研究。我们发现,与UAP患者相比,AMI患者的凝血酶 - 抗凝血酶 - III(TAT)复合物水平显著升高,全身组织纤溶酶原激活物(t-PA)活性水平降低,纤溶酶原激活物抑制剂(PAI)活性水平升高。与这些特定变化相反,两组之间C反应蛋白、纤维蛋白原和血管性血友病因子等一般急性期反应物无显著差异。对凝血(TAT复合物)与纤溶数据之间关系的研究表明,TAT复合物的血浆抗原浓度与t-PA之间存在显著正相关(P<0.02),TAT复合物与PAI-1之间也存在显著正相关(P<0.002)。这些观察结果表明,凝血和纤溶变化存在共同的病理生理机制,提示凝血活性与t-PA相关的纤溶在体内是相互关联的过程,可能发生在内皮细胞水平。